
EfficacyHigh
Studies12
Participants450
StatusAvailable
Sermorelin
Sermorelin acetate (GHRH 1-29)
Sermorelin is a synthetic 29-amino acid peptide that mimics the biologically active portion of growth hormone releasing hormone (GHRH). Originally FDA-approved in 1997 as Geref® for treating children with growth hormone deficiency, it stimulates the pituitary gland to produce natural growth hormone in physiological pulsatile patterns. Unlike direct growth hormone injections, sermorelin works with the body's feedback mechanisms to prevent overdose and maintain natural GH rhythms.
Complete Research Database
Clinical Efficacy by Dose
2.1%
Placebo
8.4%
0.5 mg
12.3%
1 mg
15.7%
2 mg
Placebo
2.1%
0.5 mg
8.4%
1 mg
12.3%
2 mg
15.7%
Source: Clinical research data
Medical Disclaimer
Clinical data presented is from peer-reviewed studies. Individual results may vary. Consult healthcare professionals before starting treatment. This information is for educational purposes only.